Form 4: Interparfums CFO Atwood Reports Stock Option Grants
Executive Stock Option Grant
Interparfums Inc. CFO and Director Michel D. Atwood reported the acquisition of various stock options with exercise prices ranging from $84.64 to $147.71, vesting through 2030.
Summary
- Michel D. Atwood, Chief Financial Officer and Director of Interparfums Inc. (IPAR), reported changes in his beneficial ownership of derivative securities.
- The filing details the acquisition of multiple tranches of 'Option-right to buy' Common Stock.
- These options have exercise prices of $97.84, $147.71, $130.60, and $84.64.
- The options vest over several years, with the earliest vesting date reported as 12/31/2023 and the latest vesting date as 12/31/2030.
- Expiration dates for these options range from 12/30/2028 to 12/30/2031.
- A total of 5,000 options with an exercise price of $97.84 were reported, vesting annually from 12/31/2023 to 12/31/2027.
- A total of 4,000 options with an exercise price of $147.71 were reported, vesting annually from 12/29/2024 to 12/29/2028.
- A total of 4,000 options with an exercise price of $130.60 were reported, vesting annually from 12/31/2025 to 12/31/2029.
- A total of 4,000 options with an exercise price of $84.64 were reported, with a transaction date of 12/31/2025 and vesting annually from 12/31/2026 to 12/31/2030.
- All reported options are directly owned by Michel D. Atwood.
Sentiment
Score: 7
Explanation: The filing reports the acquisition of stock options by a key executive, which is generally viewed positively as it aligns management's interests with shareholders. No negative information is present.
Positives
- The grant of stock options to CFO and Director Michel D. Atwood aligns his interests with those of shareholders, incentivizing long-term company performance.
- The options have various exercise prices and vesting schedules, providing ongoing motivation for executive performance over several years.
Future Outlook
NA
Industry Context
This filing is a routine disclosure of executive compensation and does not provide information directly related to broader industry trends or competitive landscape. It reflects standard practices for incentivizing key management personnel.
Stakeholder Impact
- Shareholders: Potential positive impact due to increased alignment of executive incentives with long-term company performance and value creation.
- Management: Michel D. Atwood's compensation package is enhanced, providing a long-term incentive tied to the company's stock performance.
Next Steps
- Options will continue to vest annually on various dates through 2030, subject to the terms of the grant.
- Options will expire on various dates through 2031.
Key Dates
| Date | Description |
|---|---|
| 12/31/2023 | Transaction date for 1,000 options with an exercise price of $97.84. |
| 12/29/2024 | Transaction date for 800 options with an exercise price of $147.71. |
| 12/31/2024 | Transaction date for 1,000 options with an exercise price of $97.84. |
| 12/31/2025 | Earliest transaction date reported in the filing header; transaction date for 1,000 options with $97.84 exercise price, 800 options with $147.71 exercise price, 800 options with $130.60 exercise price, and 4,000 options with $84.64 exercise price. |
| 01/05/2026 | Date the filing was signed by Michel D. Atwood's attorney-in-fact. |
| 12/31/2026 | Vesting date for 800 options with an exercise price of $84.64. |
| 12/30/2028 | Expiration date for options with an exercise price of $97.84. |
| 12/28/2029 | Expiration date for options with an exercise price of $147.71. |
| 12/30/2030 | Expiration date for options with an exercise price of $130.60. |
| 12/30/2031 | Expiration date for options with an exercise price of $84.64. |
Recommendation
holdThis Form 4 filing reports the routine grant of stock options to a key executive, aligning management incentives with shareholder value. While positive for corporate governance, it does not contain new financial performance data or strategic shifts that would warrant a change in investment recommendation. Investors should continue to monitor the company's operational and financial performance.
Keywords
Interparfums, IPAR, stock options, executive compensation, beneficial ownership, Form 4, Michel Atwood, CFO, director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.